✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. MYLAN PHARMACEUTICALS, INC.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2018-05-01||300||affects [sic].” U.S. Patent No. 6,559,158. Plaintiffs do not contend that the ’025 patent covers a new use…of the relevant patents. Plaintiffs’ motion concerns claim 8 of United States Patent No. 8,552,025 (the… This is a Hatch-Waxman case involving a patent dispute regarding pharmaceuticals: the complaints…(the “’025 patent”). ’ Plaintiffs move for partial summary judgment on Defendants’ affirmative… 3. “Foss ’954” (Deni Dec. Ex. 3.) U.S. Patent No. 5,972,954 covers methods of use of||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|